Hartgrink et al 1 reported the final results of the Dutch D1 versus D2 gastric cancer trial after 11 years of follow-up. The authors concluded that extended lymph node dissection (D2) generated no ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback